There are currently limited guidelines and recommendations on how data should be collected to assess the safety of medicines in pregnancy.

In this article, we provide an expert consensus opinion on the core data elements that should be collected when performing studies of medication safety in pregnancy.

The aim of these recommendations is to standardise data collection processes and improve the speed at which high-quality evidence-based statements can be provided about the safety of medication use in pregnancy.